Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-46.54%
↓ 255% below average
Average (8y)
-13.11%
Historical baseline
Range
High:-2.58%
Low:-46.54%
CAGR
+23.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -46.54% | -1706.8% |
| 2023 | -2.58% | +73.7% |
| 2022 | -9.81% | -74.3% |
| 2021 | -5.63% | +58.3% |
| 2020 | -13.48% | +14.0% |
| 2019 | -15.68% | -68.1% |
| 2018 | -9.33% | -46.3% |
| 2017 | -6.37% | +25.6% |
| 2016 | -8.57% | - |